eHealth in Treatment of Gestational Diabetes (eMOMGDM)
NCT: NCT04714762 · ACTIVE_NOT_RECRUITING
Brief Summary
The overall aim of the eMOM GDM-project is to develop and evaluate a novel system to clinical decision making and patient behavior change in treatment of GDM, combining diet, physical activity, sleep, heart rate (e.g. stress), and glucose monitoring within a single system (the eMOM GDM application), and linking the developed application tool for the normal health care system in a new way. In this second phase of the project, the effect of eMOM GDM application on maternal and neonatal outcomes will be evaluated in a randomized controlled study design. The follow-up study continues until 3 months postpartum.
Frequently Asked Questions
What is eHealth in Treatment of Gestational Diabetes (eMOMGDM)?
eHealth in Treatment of Gestational Diabetes (eMOMGDM) is a clinical trial registered under NCT04714762. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04714762?
The current status of NCT04714762 (eHealth in Treatment of Gestational Diabetes (eMOMGDM)) is: ACTIVE_NOT_RECRUITING.
When did eHealth in Treatment of Gestational Diabetes (eMOMGDM) start?
eHealth in Treatment of Gestational Diabetes (eMOMGDM) started on 2021-03-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.